Reaction
Uterine Polyp reporting signals
As of the last recalculation, Uterine Polyp appears in 1,775 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is COPPER (PRR 32.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Copper | 113 | 32.8 | 32.8 |
| Progesterone | 44 | 23.1 | 23.2 |
| Raloxifene Hydrochloride | 26 | 21.2 | 21.2 |
| Anastrozole | 41 | 13.4 | 13.4 |
| Etonogestrel And Ethinyl Estradiol | 23 | 12.3 | 12.3 |
| Goserelin | 13 | 11.4 | 11.4 |
| Exemestane | 20 | 11.1 | 11.1 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 22 | 11.1 | 11.1 |
| Medroxyprogesterone Acetate | 42 | 10.1 | 10.1 |
| Levonorgestrel | 139 | 8.7 | 8.7 |
| Estradiol | 57 | 8.0 | 8.0 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 5 | 6.8 | 6.8 |
| Dalfampridine | 18 | 3.0 | 3.0 |
| Etonogestrel | 6 | 1.5 | 1.5 |